SCHEMBL21758130

SCHEMBL21758130

CCCC(C)C(C)CC(C)c1cncc(C(C)(C)CC(C)C(C)C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21341339 0.71 HMGCR (0.31) —
SCHEMBL24943825 0.61 — —
SCHEMBL20691164 0.61 — —
SCHEMBL20049877 0.59 PDE10A (0.37) —
SCHEMBL25466578 0.58 — —
SCHEMBL1702135 0.57 HMGCR (0.36) —
SCHEMBL18672477 0.56 CYP11B1 (0.35) —
SCHEMBL19726994 0.56 CDK2 (0.36) —
SCHEMBL20323545 0.56 CCNA2 (0.33) —
SCHEMBL20996911 0.55 CYP17A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200061079-A1 ISOQUINOLIDINOBENZODIAZEPINE (IQB)-1(CHLOROMETHYL)-2,3-DIHYDRO-1H-BENZO[E]INDOLE (CBI) DIMERS THE CHEMISTRY RESEARCH SOLUTIONS LLC 2020-02-27 — — US disclosed
Send feedback